As shown in Figure 5B, inhibition of PDPK1 enhances docetaxel sensitivity in DU145 and PC3 but not LNCaP cells, suggesting that PDPK1 inhibitors might potentiate sensitivity of refractory PCa cells to chemotherapy (Tables 1 and 2). The gene discussed is PDPK1; the disease is posterior cortical atrophy.